PE34998A1 - Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico - Google Patents
Un atomizador nasal que contiene un esteroide intranasal y un antihistaminicoInfo
- Publication number
- PE34998A1 PE34998A1 PE00092996A PE00092996A PE34998A1 PE 34998 A1 PE34998 A1 PE 34998A1 PE 00092996 A PE00092996 A PE 00092996A PE 00092996 A PE00092996 A PE 00092996A PE 34998 A1 PE34998 A1 PE 34998A1
- Authority
- PE
- Peru
- Prior art keywords
- antihistamine
- anticolynergic
- mixtures
- atomizer containing
- nasal atomizer
- Prior art date
Links
- 230000001387 anti-histamine Effects 0.000 title abstract 2
- 239000000739 antihistaminic agent Substances 0.000 title abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 abstract 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 229960004574 azelastine Drugs 0.000 abstract 1
- 229960004495 beclometasone Drugs 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- 229960001803 cetirizine Drugs 0.000 abstract 1
- 229960000676 flunisolide Drugs 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960003088 loratadine Drugs 0.000 abstract 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 abstract 1
- 229960001664 mometasone Drugs 0.000 abstract 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 abstract 1
- 230000001932 seasonal effect Effects 0.000 abstract 1
- 229960005294 triamcinolone Drugs 0.000 abstract 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION, QUE COMPRENDE: a) UN GLUCOCORTICOIDE SELECCIONADO DE BECLOMETASONA, FLUNISOLIDA, TRIAMCINOLONA, FLUTICASONA, MOMETASONA, BUDESONIDA O MEZCLAS DE ESTOS; b) UN ANTIHISTAMINICO INHIBIDOR DE LEUCOTRIENO SELECCIONADO DE CETIRIZINA, LORATADINA, AZELASTINA O MEZCLAS DE ESTOS; c) UN VEHICULO INTRANASAL Y, OPCIONALMENTE, PUEDE CONTENER UNA AMINA SIMPATICOMIMETICA, UN AGENTE ANTIINFLAMATORIO NO ESTEROIDEO, UN INHIBIDOR O ANTAGONISTA DE LIPOXIGENASA, UN ANALGESICO NO OPIATO, UN ANTICOLINERGICO, UN MUCOLITICO O UN ANTIALERGICO ENTRE OTROS. SIENDO UTIL EN EL TRATAMIENTO DE LOS SINTOMAS DE RINOCONJUNTIVITIS ESTACIONAL O CONTINUA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57479195A | 1995-12-19 | 1995-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE34998A1 true PE34998A1 (es) | 1998-07-24 |
Family
ID=24297657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE00092996A PE34998A1 (es) | 1995-12-19 | 1996-12-18 | Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0780127A1 (es) |
| AR (1) | AR005138A1 (es) |
| CO (1) | CO4780018A1 (es) |
| PE (1) | PE34998A1 (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849263A (en) * | 1993-03-30 | 1998-12-15 | Charlotte-Mecklenburg Hospital Authority | Pharmaceutical compositions containing alkylaryl polyether alcohol polymer |
| US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
| US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
| CA2256721A1 (en) * | 1996-06-04 | 1997-12-11 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
| US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
| SE9604486D0 (sv) * | 1996-12-05 | 1996-12-05 | Astra Ab | Novel formulation |
| FR2756739B1 (fr) * | 1996-12-05 | 2000-04-28 | Astra Ab | Nouvelle formulation de budesonide |
| IL131492A0 (en) * | 1997-04-30 | 2001-01-28 | Warner Lambert Co | Topical nasal antiinflammatory compositions |
| CZ301349B6 (cs) * | 1997-12-23 | 2010-01-27 | Schering Corporation | Prostredek k lécbe respiracních a kožních onemocnení, který obsahuje alespon jednoho antagonistu leukotrienu a alespon jedno antihistaminikum |
| GB9806937D0 (en) | 1998-03-31 | 1998-05-27 | Procter & Gamble | A spray device |
| US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
| US6384038B1 (en) | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| AU2003204684B2 (en) * | 1998-04-14 | 2005-11-24 | Sepracor, Inc. | Methods and compositions using cetrizine in compostion with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition |
| AU6018899A (en) * | 1998-09-10 | 2000-04-03 | Schering Corporation | Antihistamines for treating non-infective sinusitis or otitis media |
| EP1020233A1 (en) | 1999-01-13 | 2000-07-19 | The Procter & Gamble Company | Dosing and delivering system |
| WO2000051605A1 (en) * | 1999-03-01 | 2000-09-08 | Schering Corporation | Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
| GB9918559D0 (en) * | 1999-08-07 | 1999-10-06 | Glaxo Wellcome Kk | Novel pharmaceutical formulation |
| WO2001026658A2 (en) * | 1999-10-08 | 2001-04-19 | Schering Corporation | Topical nasal treatment using desloratadine |
| DE10064950A1 (de) * | 2000-12-23 | 2002-07-11 | Impetus Ag Basel | Thixotropes Nasenspray |
| PL208686B1 (pl) | 2001-09-18 | 2011-05-31 | Nycomed Danmark Aps | Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| PL373433A1 (en) | 2002-08-30 | 2005-08-22 | Altana Pharma Ag | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| WO2004026263A2 (en) | 2002-09-20 | 2004-04-01 | Fmc Corporation | Cosmetic composition containing microcrystalline cellulose |
| WO2004082589A2 (en) * | 2003-03-20 | 2004-09-30 | Ranbaxy Laboratories Limited | Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| TW200522932A (en) * | 2003-09-15 | 2005-07-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| PL2486942T3 (pl) | 2004-11-24 | 2019-05-31 | Meda Pharmaceuticals Inc | Kompozycje zawierające azelastynę oraz sposoby ich stosowania |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| KR20070121786A (ko) | 2005-03-23 | 2007-12-27 | 엘란 파마 인터내셔널 리미티드 | 나노입자형 코르티코스테로이드 및 항히스타민 제제 |
| RU2308272C1 (ru) * | 2006-08-30 | 2007-10-20 | Общество с ограниченной ответственностью "ЮНАЛ" | Лекарственная композиция, обладающая антиаллергическим и противовоспалительным действием |
| US20100099650A1 (en) * | 2006-10-10 | 2010-04-22 | Knauer Kent A | Nasal spray composition and method for treating rhinitis, sinusitis or both |
| WO2011141929A2 (en) | 2010-05-11 | 2011-11-17 | Cadila Healthcare Limited | Aqueous pharmaceutical compositions of fluticasone and olopatadine |
| RU2543326C2 (ru) * | 2012-08-21 | 2015-02-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения зуда кожи |
| US9962397B2 (en) | 2014-04-16 | 2018-05-08 | John T. Given | Intranasal medication delivery device and method of use thereof |
| US11135155B2 (en) | 2014-07-08 | 2021-10-05 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| CN107929738A (zh) * | 2017-11-28 | 2018-04-20 | 贵州云峰药业有限公司 | 一种含盐酸氮卓斯汀的组合物 |
| WO2022098319A1 (en) * | 2020-11-09 | 2022-05-12 | Pharmactive Ilac Sanayi Ve Ticarey A.S. | Pharmaceutical compositions comprising azelastine, beclomethasone and relevant excipients |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4136163A (en) | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
| GB1421743A (en) | 1972-04-18 | 1976-01-21 | Wilkinson Sword Ltd | Ingestible topical and other compositions |
| ZA821577B (en) | 1981-04-06 | 1983-03-30 | Boots Co Plc | Therapeutic agents |
| JPS5888334A (ja) | 1981-11-20 | 1983-05-26 | Takasago Corp | ３−ｌ−メントキシプロパン−１、２−ジオ−ル |
| US4767612A (en) | 1987-01-23 | 1988-08-30 | Rorer Pharmaceutical Corporation | Triamcinolone acetonide for the treatment of allergic rhinitis |
| US4873259A (en) | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| IL88433A0 (en) | 1987-11-25 | 1989-06-30 | Merck Frosst Canada Inc | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them |
| TW401300B (en) * | 1992-12-25 | 2000-08-11 | Senju Pharma Co | Antiallergic composition for ophthalmic or nasal use |
-
1996
- 1996-12-05 EP EP96308852A patent/EP0780127A1/en not_active Withdrawn
- 1996-12-13 CO CO96065607A patent/CO4780018A1/es unknown
- 1996-12-18 AR ARP960105765A patent/AR005138A1/es not_active Application Discontinuation
- 1996-12-18 PE PE00092996A patent/PE34998A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO4780018A1 (es) | 1999-05-26 |
| EP0780127A1 (en) | 1997-06-25 |
| AR005138A1 (es) | 1999-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE34998A1 (es) | Un atomizador nasal que contiene un esteroide intranasal y un antihistaminico | |
| DK1719512T3 (da) | Sarsasapogenin og smilagenin til behandling af cognitive dysfunktioner | |
| AR025923A1 (es) | Nueva combinacion de loteprednol y antihistaminicos | |
| IT1317904B1 (it) | Formulazione farmaceutica di propionato di fluticasone. | |
| CY1107512T1 (el) | Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους | |
| AR020999A1 (es) | Composiciones y proceso para la elaboracion de isotretinoina | |
| NO20013966D0 (no) | Kombinasjoner for behandling av sykdommer som involverer angiogenese | |
| AR040553A1 (es) | Combinacion que comprende un inhibidor de ibat y tratamiento terapeutico | |
| HUP0000487A2 (hu) | Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok | |
| TW200504078A (en) | Therapeutically active compounds and their use | |
| TR200301613T2 (tr) | Sapogenin türevleri, bunların sentezi ve kullanımı, bunların kullanım metotları. | |
| PT1037604E (pt) | Composicoes farmaceuticas de aerossol | |
| EE200100136A (et) | Atsetüülkoliini esteraasi inhibiitori ja psühhoosivastase toimeaine kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni- ja psühhoosihäirete raviks, ning neid aineid sisaldav farmatseutiline kompositsioon | |
| DK279790A (da) | Aromatiske steroid-5-alfa-reduktaseinhibitorer | |
| DK0712311T3 (da) | Antiglucocorticoidsteroider til behandling af angstlidelser | |
| SE9604751D0 (sv) | New therapy | |
| IL164159A0 (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
| NO20025394L (no) | Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmon¶re sykdommer | |
| DK1467762T3 (da) | Anvendelse af en H1-antagonist og rimexolon som et sikkert steroid til behandling af rhinitis | |
| IL160649A0 (en) | Methods for inhibiting cognitive deterioration in adults with down syndrome | |
| PE20011005A1 (es) | Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares | |
| MXPA05008347A (es) | Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis. | |
| ATE433457T1 (de) | Angiogen-wirkende trisulfat steroide und deren verwendung | |
| ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest | |
| ATE377020T1 (de) | Kristallines gamma-lacton der17beta-hydroxy- |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FX | Voluntary withdrawal |